Pharmacokinetic, pharmacodynamic and pharmacogenetic research on biomarkers in cancer patients with special response to pharmacological therapy

Pharmacokinetic, pharmacodynamic and pharmacogenetic research on biomarkers in cancer patients with special response to pharmacological therapy - A translational research in cancer patients with special response to pharmacological therapy

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011798

Enrollment

600

Registered

2013-10-01

Start date

2013-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

Blood sampling Patients may have additional sampling of specimens only if necessary. e.g. bone marrow, urine, cerebrospinal fluid, body cavity fluid, skin, lymph node, saliva, oral mucous membrane,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Pathologically proven malignant tumor 2) Administration of pharmacological therapy, including the planning phase 3) Aged 16 years or older at the time of enrollment 4) Written informed consent 5) Feasible for sampling adequate specimens

Exclusion criteria

Exclusion criteria: Judged to be inadequate for enrollment by the investigator

Countries

Japan

Contacts

Public ContactYoshinori Imamura

Kobe University Hospital Medical Oncology / Hematology, Department of Medicine

nagatani@med.kobe-u.ac.jp078-382-5820

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026